ALTACE® (ramipril) is indicated to reduce the risk of stroke,
heart attack, or death from cardiovascular (CV) causes in patients 55 or older
who are at high risk for all events either because of a history of CV disease
or because of diabetes plus at least one other CV risk factor.
For more complete information on Altace, please visit
http://www.altace.com/
as this is the official website for altace.